Virulence markers of vancomycin resistant enterococci isolated from infected and colonized patients

Journal of Global Infectious Diseases

Volumn 6, Issue 4, 2014, Pages 157-163

  Biswas, Priyanka Paul ^a   Dey, Sangeeta ^a   Adhikari, Luna ^b   Sen, Aninda ^a  

^a Katihar Medical College and Hospital   (India)

^b SIKKIM MANIPAL UNIVERSITY   (India)

Author keywords

Blood stream infection; Catheter induced infection; Urinary tract infection; Vancomycin intermediate enterococci; Vancomycin resistant enterococci

Indexed keywords

ADHESIN; DEOXYRIBONUCLEASE; GELATINASE; HEMOLYSIN; PROTEINASE; TRIACYLGLYCEROL LIPASE; VANCOMYCIN; VIRULENCE FACTOR;

AGAR DILUTION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; BACTERIUM ISOLATION; BIOFILM; BLOODSTREAM INFECTION; CATHETER INFECTION; DISEASE ASSOCIATION; DISK DIFFUSION; ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; ERYTHROCYTE; FECES ANALYSIS; GASTROINTESTINAL TRACT; HEMAGGLUTINATION TEST; HOSPITAL ADMISSION; HOSPITAL PATIENT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; RABBIT; STRAIN DIFFERENCE; URINARY TRACT INFECTION; VANCOMYCIN INTERMEDIATE ENTEROCOCCUS; VANCOMYCIN RESISTANT ENTEROCOCCUS; WOUND INFECTION;

EID: 84914162037     PISSN: 0974777X     EISSN: 09748245     Source Type: Journal    
DOI: 10.4103/0974-777X.145242     Document Type: Article

References (21)

1. Murray BE. The life and times of the Enterococcus. Clin Microbiol Rev 1990;3:46-65
2. Huycke MM, Sahm DF, Gilmore MS. Multiple Drug resistant Enterococci: The Nature of the Problem and Agenda for the future. Emerging infectious Diseases 1998;4:239-49
3. Oli AK, Raju S, Rajeshwari, Nagaveni S, Kelmani CR. Biofilm formation by Multidrug resistant Enterococcus fecalis (MDEF) originated from clinical samples. J Microbiol Biotechnol Res 2012;2:284-8
4. Toledo Arana A, Valle J, Solano C, Arrizubieta MJ, Cucarella C, Lamata M et al. The enterococcal surface protein, Esp is involved in Enterococcus fecalis biofilm formation. Appl Enviorn Microbiol 2001;67:4538-45
5. Johnson AP. The pathogenecity of enterococci. J of Antimicrob Chemother 1994;33:1083-9
6. Jahangiri S, Talebi M, Eslami G, Pourshafie MR. Prevalence of virulence factors and antibiotic resistance in vancomycin- resistant Enterococcus faecium isolated from sewage and clinical samples in Iran. Ind J of Med Microbiol 2010;28:337-41
7. Lempiainem H, Kinnunen K, Mertanen A, von Wright A. Occurance of virulence factors among human intestinal enterococcal isolates. Lett Appl Microbiol 2005;41:341-44
8. Koneman EW, Allen SD, Janda WM, Schreckenberger PC, Winn WC editors. Gram positive cocci Part 2: Streptococci, Enterococci and the Streptococcus like bacteria. In: Colour Atlas and Text book of Diagnostic Microbiology. 6th ed. Philadelphia:Lippincott; 2006. p. 725-33
9. Furumura MT, Figueiredo PM, Carbonell GV, Darini AL, Yano T. Virulence associated characteristics of Enterococcus fecalis strains isolated from clinical sources. Braz J Microbiol 2006;37:230-6
10. Gulhan T, Aksakal A, Ekin HI, Savasan S, Boynukara B. Virulence factors of Enterococcus fecium and Enterococcus fecalis strains Isolated from Humans and Pets. Turk J Vet Anim Sci 2006;30:477-82
11. Carvalho Mda G,Teixeira LM. Hemagglutination properties of Enterococcus. Current Microbiol 1995;30:265-68
12. Betty AF, Daniel LS, Weissfeld AS, editors. Overview of Bacterial Identifications Methods and Strategies. In: Bailey & Scott's Diagnostic Microbiology.12th ed. Mosby Elsevier, Missouri; 2007. p. 216-41
13. Collee JG, Duguid JP, Fraser AG, Marmion BS Simmons A editors. Laboratory strategy in the diagnosis of infective syndromes. In: Mackie Mc Cartney Practical Medical Microbiology. 14th ed. Churchill livingstone; 2006. p. 113-29
14. Prabakaran K, Aberna AR. Evaluation for the association of virulence determinants among E. fecalis with its clinical outcome. Int J of Biol Med Res 2011;2:523-27
15. CLSI. Performance standards for antimicrobial susceptibility testing: Twenty-third informational supplement, M100-S23, January. Vol. 33 No. 1. CLSI; 2008. p. 90-93
16. Murray PR, Baron EJ, Jorgensen JH, Landry ML and Pfaller MA, editors. Special Phenotypic Methods for Detecting Antibacterial Resistance. In : Manuel of Clinical Microbiology. 9th ed. Washington DC: ASM Press; 2007. p. 1152-72
17. Ike Y, Hasimoto H & Clewell DB. High incidence of hemolysin production by Enterococcus(Streptococcus) faecalis strains associated with human parenteral infections. J of Clin Microbiol 1987;25:1524-8
18. Coque TM, Patterson JE, Steckelberg JM, Murray BE. Incidence of hemolysin ,gelatinase and aggregation substance among enterococci isolated from patients with endocarditis and other infections and from feces of hospitalized and community-based persons. Journal of Infectious Diseases 1995;171:1223-9
19. Semedo T, Almeida Santos M, Martins P, Silva Lopes MF, Figueiredo Marques JJ, Tenreiro R, et al. Comparitive study using type strains and clinical and food isolates to examine hemolytic activity and occurance of the cyl operon in enterococci. J Clin Microbiol 2003;41:2569-76
20. Elsner HA, Sobottka I,Mack D, Claussen M, Laufs R, Wirth R. Virulence factors of Enterococcus faecalis and Enterococcus faecium blood culture isolates 2000;19:39-42
21. Oli AK, Raju S, Rajeshwari D, Nagaveni. S, Chandrakanth .R. Biofilm formation by multidrug resistant Enterococcus fecalis originated from clinical samples. J. Microbiol. Biotech. Res 2012;2:284-8